Join to View Full Profile
725 W Lombard StSuite S220Baltimore, MD 21201
Dr. Kattakuzhy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
George Washington UniversityResidency, Internal Medicine, 2009 - 2012
Eastern Virginia Medical SchoolClass of 2009
Certifications & Licensure
MD State Medical License 2013 - 2026
DC State Medical License 2009 - 2022
VA State Medical License 2009 - 2012
American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder Start of enrollment: 2021 Jan 01
Publications & Presentations
PubMed
- Elevated rate of suicide risk in individuals with opioid use disorder.Max Spaderna, Elana Rosenthal, Sun Jung Kang, Rahwa Eyasu, Emade Ebah
The American Journal on Addictions. 2025-03-11 - A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal Cytology.Omar Harfouch, Darren Whitfield, Tural Mammadli, Rahwa Eyasu, Connor Volpi
AIDS Patient Care and Stds. 2025-02-01 - 1 citationsHigh Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth.Omar Harfouch, Andrea Lisco, Habib Omari, Rahwa Eyasu, Ashley Davis
Open Forum Infectious Diseases. 2024-12-01
Press Mentions
Allyship in Action at the 2025 UMBrella SymposiumMarch 21st, 2025- Leaders in Health Care 2022: Dr. Sarah Kattakuzhy and Dr. Elana Rosenthal, UM School of MedicineOctober 7th, 2022
NIH to Test Experimental Drug to Curb Drug CravingsMarch 22nd, 2019- Join now to see all
Grant Support
- ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance UseUNIVERSITY OF MARYLAND BALTIMORE2024–2029
- CJ-PRISM: Understanding the Impact of Criminolegal System Involvement on a Peer-Delivered Intervention to Improve Retention and Polysubstance UseUNIV OF MARYLAND, COLLEGE PARK2022–2025
- Evaluating the role of stigma in polysubstance use and medication for opioid use disorder treatment in an underserved, rural settingUNIV OF MARYLAND, COLLEGE PARK2022–2025
- CJ-PRISM: Understanding the Impact of Criminolegal System Involvement on a Peer-Delivered Intervention to Improve Retention and Polysubstance UseUNIV OF MARYLAND, COLLEGE PARK2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
